Which Document Control Software Supports FDA Electronic Signature Requirements?

A practical guide to the 21 CFR Part 11 criteria your e-signature workflow must meet, and how to evaluate the systems that claim to meet them.

For quality teams at FDA-regulated organizations, adding an electronic signature to a document is only part of the equation. 21 CFR Part 11 electronic signatures must meet specific requirements designed to ensure electronic records and signatures are trustworthy, reliable, and generally equivalent to their paper counterparts.

That makes the software behind the signature important. The right document control software must provide the technical controls needed to support Part 11 compliance while fitting into the review, approval, and change control processes your team already manages. 

What Makes Document Control Software Part 11 Compliant?

When you must meet FDA electronic signature requirements, the right software is one that enforces Part 11 controls for e-signatures, including unique user credentials, signature manifestations, record linking, and secure audit trails, all within a validated system.

But there is an important distinction: the FDA does not certify individual electronic systems or methods for obtaining Part 11-compliant electronic signatures.

Organizations are responsible for determining which requirements apply and implementing appropriate system controls, validation, and procedures. 

What Does 21 CFR Part 11 Require for Electronic Signatures?

• When electronic signatures are used under Part 11, key requirements include: • Unique electronic signatures: Each signature must be tied to one individual and cannot be reused or reassigned.

• Two distinct identification components: For example, user ID and password.

• Signature manifestations: These must show the signer’s printed name, the date and time of signing, and the meaning of the signature, such as review, approval, or authorship.

• Signatures linked to their records: That way, they cannot be copied, removed, or transferred.

• Audit trails: These must be secure, computer-generated, and time stamped. 
  
  For organizations operating under EU GMP requirements, EU Annex 11 carries comparable expectations for electronic signatures. 

Where Common Electronic Signature Systems Can Fall Short

SharePoint add-ons, shared drives, and emailed PDFs often lack enforced signature meaning, record linking, or complete audit trails.  

Standalone e-signature tools, on the other hand, may capture a signature but may not connect it to document version control, training, or change control.

For quality teams, those gaps can mean more work establishing who approved what, which version was current, and what happened over time, increasing audit risk. 

What to Look for in Part 11 Compliant E-Signature Software

When evaluating Part 11 compliant e-signature software, look beyond signature capture. Make sure your software offers:

• Built-in Part 11 e-signature controls, not a bolt-on

• Signatures embedded in review, approval, and change control workflows

• Full audit trails across document, user, and training activity

• Validation support, such as IQ/OQ/PQ documentation

• Configurability to match existing SOPs without custom code 

How ENSUR Supports 21 CFR Part 11 Electronic Signatures

ENSUR brings the controls needed to support Part 11 compliance directly into your existing quality workflows.

Electronic signatures are built into automated review and approval routing, with enforced version control and complete audit trails to maintain traceability.

ENSUR also connects document control and training management, so training acknowledgments stay tied to SOP changes. ENSUR is available in a validated GxP cloud environment with IQ/OQ/PQ documentation support or as an on-premises deployment. And because workflows can be configured to match your existing SOPs without custom code, quality teams get the controls auditors expect without taking on enterprise QMS cost or complexity.

The impact extends to audit preparation, too. One regulated global manufacturer reduced audit preparation time by more than 90% after moving to ENSUR.

If you’re evaluating document control software for an FDA-regulated organization, ENSUR can help you bring electronic signatures, document control, audit trails, training, and quality workflows together in one configurable system built to support your compliance requirements.

Request a demo today to see how ENSUR can support your quality team. 

Frequently Asked Questions About 21 CFR Part 11 Electronic Signatures

Sources

• Full regulation

  21 CFR Part 11, Electronic Records; Electronic Signatures: https://www.ecfr.gov/current/title-21/part-11

  Section 2 citations (21 CFR Part 11)

  • 11.1 Scope (electronic signatures as equivalent to handwritten): https://www.ecfr.gov/current/title-21/part-11/section-11.1

  • 11.10 Controls for closed systems (audit trails, validation, access controls): https://www.ecfr.gov/current/title-21/part-11/section-11.10

  • 11.50 Signature manifestations (name, date and time, meaning): https://www.ecfr.gov/current/title-21/part-11/section-11.50

  • 11.70 Signature/record linking: https://www.ecfr.gov/current/title-21/part11/section-11.70

  • 11.100 General requirements (unique to one individual): https://www.ecfr.gov/current/title-21/part-11/section-11.100

  • 11.200 Electronic signature components and controls: https://www.ecfr.gov/current/title-21/part-11/section-11.200

  • 11.300 Controls for identification codes and passwords: https://www.ecfr.gov/current/title-21/part-11/section-11.300

  • Subpart C, all electronic signature requirements in one view: https://www.ecfr.gov/current/title-21/part-11/subpart-C

• Part 11, Electronic Records; Electronic Signatures, Scope and Application (September 2003): https://www.fda.gov/regulatory-information/search-fda-guidance-documents/part11-electronic-records-electronic-signatures-scope-and-application

• EU Annex 11 

  EudraLex Volume 4, Annex 11: Computerised Systems (current version): https://health.ec.europa.eu/system/files/2016-11/annex11_01-2011_en_0.pdf